| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/16/2006 | US20060058312 Stabilized aqueous preparation for injection |
| 03/16/2006 | US20060058311 Combinations for the treatment of diseases involving cell proliferation |
| 03/16/2006 | US20060058310 Remedies for vertebral canal stenosis |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058308 Vanilloid receptor ligands and their use in treatments |
| 03/16/2006 | US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 03/16/2006 | US20060058306 Solubilized topoisomerase poison agents |
| 03/16/2006 | US20060058305 Antiproliferative agents such as 3-(3-trifluoromethylphenyl)cinnolin-5-ol |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058303 7-Phenylimidazo[1,2-b][1,2,4]triazine derivatives; treating anxiety; for example, 2-[4-(3-trifluoromethylimidazo[1,2-b][1,2,4]triazin-7-yl)pyridin-2-yl]-benzonitrile |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058301 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid |
| 03/16/2006 | US20060058300 Intermediates of bupropion metabolites synthesis |
| 03/16/2006 | US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058297 Novel compounds useful for modulating abnormal cell proliferation |
| 03/16/2006 | US20060058296 Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase |
| 03/16/2006 | US20060058295 Novel compounds as pharmaceutical agents |
| 03/16/2006 | US20060058294 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 03/16/2006 | US20060058293 Combination of bupropion and a second compound for affecting weight loss |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058291 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058287 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/16/2006 | US20060058286 Methods of treating HIV infection |
| 03/16/2006 | US20060058285 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 03/16/2006 | US20060058284 Compounds such as tert-butyl 3-(3,4-dichlorophenyl)-3-[3-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)propyl]pyrrolidine-1-carboxylate;useful in the inhibition of HIV replication, therapy and prophylaxis of an HIV infection, and in therapy of the resulting acquired immune deficiency syndrome (AIDS) |
| 03/16/2006 | US20060058283 Compositions comprising ubiquinones |
| 03/16/2006 | US20060058282 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 03/16/2006 | US20060058281 preparation of Ceftiofar sodium; high yield and purity |
| 03/16/2006 | US20060058280 Preparation of penicillin procaine |
| 03/16/2006 | US20060058279 Topical compositions comprising ascomycins |
| 03/16/2006 | US20060058277 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 03/16/2006 | US20060058276 Processes for the preparation and purification of rocuronium bromide |
| 03/16/2006 | US20060058275 Processes for preparing stabilized, highly pure rocuronium bromide |
| 03/16/2006 | US20060058274 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/16/2006 | US20060058273 A combination of a cephalosporin. prednisolone and a carrier to treat milk-producing animals having clinical mastis of the mammary gland; increased antiinflammatory efficiency without the immunosuppressive side effects; bovine mastitis; veterninary medicine |
| 03/16/2006 | US20060058272 Pharmaceutical composition for use as a contraceptive |
| 03/16/2006 | US20060058271 Methods for screening, studying, and treating dissorders with a component of mercurial toxicity |
| 03/16/2006 | US20060058270 Ruthenium anticancer complexes |
| 03/16/2006 | US20060058269 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 03/16/2006 | US20060058268 Compounds and methods for treating diabetic vascular diseases |
| 03/16/2006 | US20060058267 Pharmaceutical compositions comprising a NOS inhibitor |
| 03/16/2006 | US20060058266 containing 2'-O-methyl modified nucleoside; oligonucleotide having a nucleotide sequence consisting of from 12 to 23 nucleotides in length sufficiently complementary to a microRNA target sequence of about 12 to 23 nucleotides, conjugate with a cholesterol or steroid; for inhibiting gene expression |
| 03/16/2006 | US20060058265 Topical antiviral formulations |
| 03/16/2006 | US20060058264 (2S,4aS,6aR,7R,9S,10aS,10bR)-9-(hydroxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester, for treating pain, drug or alcohol addiction; side effect reduction |
| 03/16/2006 | US20060058263 Heat pasturized liquids containing glucosamine |
| 03/16/2006 | US20060058262 New injectable formulations containing progesterone |
| 03/16/2006 | US20060058261 Chitin derivatives for hyperlipidemia |
| 03/16/2006 | US20060058260 Combination therapy with gemcitabine and zd6126 |
| 03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058250 Methods of treating proliferative skin diseases using carbazole derivatives |
| 03/16/2006 | US20060058248 Processes for the preparation of 6-11 bicyclic erythromycin derivatives |
| 03/16/2006 | US20060058247 Methods and compositions for treating cystic fibrosis |
| 03/16/2006 | US20060058246 Macrolide compounds endowed with antiinflammatory activity |
| 03/16/2006 | US20060058245 Identifying a subject at risk of developing Beryllium Disease; contacting cells with an agent to increase transport of thiol-containing compound; modulating secretion of thiol-containing compound(s); attenuating the disease |
| 03/16/2006 | US20060058244 New pyrazole derivatives and diabetic medicine containing them |
| 03/16/2006 | US20060058243 Methods and compositions for treating diabetes mellitis |
| 03/16/2006 | US20060058242 Dipeptide derivatives |
| 03/16/2006 | US20060058241 Methods of treating disorders having a component of mercury toxicity |
| 03/16/2006 | US20060058232 Methods of treating cancer using a modified endostatin protein |
| 03/16/2006 | US20060058225 Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 03/16/2006 | US20060058224 Methods of treating obesity with combination therapeutics |
| 03/16/2006 | US20060058217 Compositions and methods for treatment of ovarian cancer |
| 03/16/2006 | US20060058206 Aqueous activated components conveyed in a non-aqueous carrier system |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057644 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/16/2006 | US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 03/16/2006 | US20060057562 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/16/2006 | US20060057252 Composition containing calcium pantothenate and vitamin |
| 03/16/2006 | US20060057234 Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra |
| 03/16/2006 | US20060057232 Method of altering age perception |
| 03/16/2006 | US20060057231 Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform |
| 03/16/2006 | US20060057229 External skin preparations for suppressing sebum secretion |
| 03/16/2006 | US20060057228 Weight loss composition |
| 03/16/2006 | US20060057225 Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| 03/16/2006 | US20060057219 Method for preparing a polymer micelle pharmaceutical preparation containing drug for injection |
| 03/16/2006 | US20060057218 N-[1-butyl-4-piperidinylmethyl[3,4-dihydro-2 oxazino[3,2-a indole-10 carboxamide as drugs with Cahpo4 or Ca3/po4/2 fillers or binders for use in treatment of irritable bowel syndrome, urinry incontience or arrhythmias |
| 03/16/2006 | US20060057214 Process for the produciton of cross-linked gelatin beadlets |
| 03/16/2006 | US20060057210 for oral administration, reducing the range in daily dosages required to control pain in human patients; specified mean maximum plasma concentration |
| 03/16/2006 | US20060057205 Phenylepherine containing dosage form |
| 03/16/2006 | US20060057204 Pharmaceutical compositions containing venlafaxine |
| 03/16/2006 | US20060057203 Modified release formulations of oxcarbazepine and derivatives thereof |
| 03/16/2006 | US20060057202 Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
| 03/16/2006 | US20060057198 Drug delivery from embolic agents |
| 03/16/2006 | US20060057195 Stable solid preparations |
| 03/16/2006 | US20060057188 Dietary supplement energy-providing to skeletal muscles |
| 03/16/2006 | US20060057186 Oral contraceptive multivitamin compound and methods of administration |
| 03/16/2006 | US20060057185 Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 03/16/2006 | US20060057182 Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time |
| 03/16/2006 | US20060057179 Therapeutic polyesters and polyamides |
| 03/16/2006 | US20060057169 Topical anhydrous delivery system for antioxidants |
| 03/16/2006 | US20060057168 Microemulsion process and composition |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057154 Compositions for inducing of immunotolerance |